BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 26719363)

  • 1. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.
    Bitzan M; Babayeva S; Vasudevan A; Goodyer P; Torban E
    Pediatr Nephrol; 2012 Dec; 27(12):2217-26. PubMed ID: 22538781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel in vitro assays to detect circulating permeability factor(s) in idiopathic focal segmental glomerulosclerosis.
    den Braanker DJW; Maas RJ; Deegens JK; Yanginlar C; Wetzels JFM; van der Vlag J; Nijenhuis T
    Nephrol Dial Transplant; 2021 Jan; 36(2):247-256. PubMed ID: 33155059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
    Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
    Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis.
    Chang JW; Pardo V; Sageshima J; Chen L; Tsai HL; Reiser J; Wei C; Ciancio G; Burke GW; Fornoni A
    Transplantation; 2012 Jun; 93(12):1238-44. PubMed ID: 22499148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis.
    Schwartz MM
    Ren Fail; 2000 Nov; 22(6):663-84. PubMed ID: 11104157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.
    Babayeva S; Miller M; Zilber Y; El Kares R; Bernard C; Bitzan M; Goodyer P; Torban E
    Pediatr Nephrol; 2011 Jul; 26(7):1071-81. PubMed ID: 21380797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation.
    Shoji J; Mii A; Terasaki M; Shimizu A
    Nephron; 2020; 144 Suppl 1():65-70. PubMed ID: 33260184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis and renal transplantation.
    Crosson JT
    Transplant Proc; 2007 Apr; 39(3):737-43. PubMed ID: 17445586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel diagnostic and therapeutic techniques reveal changed metabolic profiles in recurrent focal segmental glomerulosclerosis.
    Müller-Deile J; Sarau G; Kotb AM; Jaremenko C; Rolle-Kampczyk UE; Daniel C; Kalkhof S; Christiansen SH; Schiffer M
    Sci Rep; 2021 Feb; 11(1):4577. PubMed ID: 33633212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal segmental glomerulosclerosis; why does it occur segmentally?
    Nagata M; Kobayashi N; Hara S
    Pflugers Arch; 2017 Aug; 469(7-8):983-988. PubMed ID: 28664408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis.
    Taneda S; Honda K; Ohno M; Uchida K; Nitta K; Oda H
    Virchows Arch; 2015 Oct; 467(4):449-58. PubMed ID: 26266776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.
    Campbell KN; Tumlin JA
    Am J Nephrol; 2018; 47 Suppl 1(Suppl 1):14-29. PubMed ID: 29852493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.
    Bertelli R; Ginevri F; Caridi G; Dagnino M; Sandrini S; Di Duca M; Emma F; Sanna-Cherchi S; Scolari F; Neri TM; Murer L; Massella L; Basile G; Rizzoni G; Perfumo F; Ghiggeri GM
    Am J Kidney Dis; 2003 Jun; 41(6):1314-21. PubMed ID: 12776285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.